1,489 results on '"Krucoff, Mitchell"'
Search Results
2. Conversations in cardiology: Late career transitions—Retool, retire, refocus
3. Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
4. 1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program
5. Statistical considerations for cardiovascular clinical trials straddling the continuum of pandemic phases
6. Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial
7. Consensus minimum core data elements adapted to peripheral vascular intervention in the drug-eluting era: Consensus report from the Registry Assessment of Peripheral Interventional Devices (RAPID) Pathways “LEAN” working group
8. Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention
9. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI
10. Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions
11. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT
12. Minimum Core Data Elements for Transcatheter Mitral Therapies: Scientific Statement by PASSION CV, HVC, and TVTR
13. Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction
14. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent
15. One- Versus Three-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease
16. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium
17. Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
18. Randomized evaluation of vessel preparation with orbital atherectomy prior to drug-eluting stent implantation in severely calcified coronary artery lesions: Design and rationale of the ECLIPSE trial
19. Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial
20. Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial area
21. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI
22. Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies
23. Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI
24. Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction
25. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions
26. Definitions of adverse events associated with extracorporeal membrane oxygenation in children: results of an international Delphi process from the ECMO-CENTRAL ARC
27. Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
28. Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 years.
29. Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study
30. Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs
31. Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease Consensus Definitions From Peripheral Academic Research Consortium (PARC)
32. Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events
33. Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry
34. Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction
35. Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
36. Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury
37. Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)
38. Direct Stenting versus Conventional Stenting in Patients with ST-Segment Elevation Myocardial Infarction—A COMPARE CRUSH Sub-Study
39. Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)
40. TCT-170 Analysis of Coronary Artery Stenosis in the ALERTS Pivotal Study
41. SUPPORT-1 (Subjects Undergoing PCI and Peri-Operative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective PCI
42. Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry
43. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations
44. Advancing medical device innovation through collaboration and coordination of structured data capture pilots: Report from the Medical Device Epidemiology Network (MDEpiNet) Specific, Measurable, Achievable, Results-Oriented, Time Bound (SMART) Think Tank
45. Understanding operator stent choice in the catheterization laboratory using a pre-procedure survey: Opportunities for quality improvement
46. The ‘chessboard of healing strategies’: A cardiological application
47. E-11 | Contrast Fractional Flow Reserve to Evaluate the Severity of Angiographically Intermediate Coronary Lesions: Results from the Adenosine Contrast Correlations in Evaluating Revascularization (ACCELERATION) Study
48. Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment–Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial
49. Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry
50. SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.